Details for New Drug Application (NDA): 020589

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

NDA 020589 describes CHILDREN'S ADVIL-FLAVORED, which is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from one supplier. There is one patent protecting this drug. Additional details are available on the CHILDREN'S ADVIL-FLAVORED profile page.

The generic ingredient in CHILDREN'S ADVIL-FLAVORED is ibuprofen. There are sixty-four drug master file entries for this compound. Two hundred and twenty suppliers are listed for this compound. Additional details are available on the ibuprofen profile page.

Summary for 020589

Tradename:	CHILDREN'S ADVIL-FLAVORED
Applicant:	Glaxosmithkline
Ingredient:	ibuprofen
Patents:	1
Formulation / Manufacturing:	see details

Medical Subject Heading (MeSH) Categories for 020589

Analgesics, Non-Narcotic
Anti-Inflammatory Agents, Non-Steroidal
Cyclooxygenase Inhibitors

Suppliers and Packaging for NDA: 020589

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
CHILDREN'S ADVIL	ibuprofen	SUSPENSION;ORAL	020589	NDA	Wyeth Consumer Healthcare LLC	0573-0170	0573-0170-01	1 BOTTLE in 1 CARTON (0573-0170-01) > 30 mL in 1 BOTTLE
CHILDREN'S ADVIL	ibuprofen	SUSPENSION;ORAL	020589	NDA	Wyeth Consumer Healthcare LLC	0573-0170	0573-0170-30	1 BOTTLE in 1 CARTON (0573-0170-30) > 120 mL in 1 BOTTLE

Profile for product number 001

Active Rx/OTC/Discontinued:	OTC	Dosage:	SUSPENSION;ORAL			Strength	100MG/5ML
Approval Date:	Jun 27, 1996	TE:		RLD:	No

Profile for product number 002

Active Rx/OTC/Discontinued:	OTC	Dosage:	SUSPENSION;ORAL			Strength	100MG/5ML
Approval Date:	Nov 7, 1997	TE:		RLD:	No
Patent:	Start Trial	Patent Expiration:	May 25, 2024	Product Flag?	Y	Substance Flag?		Delist Request?

Expired US Patents for NDA 020589

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Glaxosmithkline	CHILDREN'S ADVIL	ibuprofen	SUSPENSION;ORAL	020589-001	Jun 27, 1996	Start Trial	Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.